Debt-to-equity of Arcutis Biotherapeutics, Inc. from 30 Sep 2020 to 31 Dec 2025

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Arcutis Biotherapeutics, Inc. quarterly Debt-to-equity in % history and change rate from 30 Sep 2020 to 31 Dec 2025.
Arcutis Biotherapeutics, Inc. Debt-to-equity for the quarter ending 31 Dec 2025 was 138%, a 2.1% increase year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Change (%)

Arcutis Biotherapeutics, Inc. Quarterly Debt-to-equity (%)

Period	Value	YoY Chg	Change %	Date
Q4 2025	138%	+2.9%	+2.1%	31 Dec 2025
Q3 2025	137%	-22%	-14%	30 Sep 2025
Q2 2025	149%	-36%	-19%	30 Jun 2025
Q1 2025	145%	-80%	-36%	31 Mar 2025
Q4 2024	136%	-140%	-51%	31 Dec 2024
Q3 2024	159%	-43%	-21%	30 Sep 2024
Q2 2024	185%	+48%	+35%	30 Jun 2024
Q1 2024	225%	+124%	+123%	31 Mar 2024
Q4 2023	275%	+201%	+269%	31 Dec 2023
Q3 2023	203%	+147%	+266%	30 Sep 2023
Q2 2023	137%	+105%	+334%	30 Jun 2023
Q1 2023	101%	+81%	+409%	31 Mar 2023
Q4 2022	75%	+63%	+557%	31 Dec 2022
Q3 2022	55%	+49%	+818%	30 Sep 2022
Q2 2022	32%	+25%	+352%	30 Jun 2022
Q1 2022	20%	+11%	+128%	31 Mar 2022
Q4 2021	11%	+1.5%	+15%	31 Dec 2021
Q3 2021	6%	-5.8%	-49%	30 Sep 2021
Q2 2021	7%			30 Jun 2021
Q1 2021	8.7%			31 Mar 2021
Q4 2020	9.8%			31 Dec 2020
Q3 2020	12%			30 Sep 2020

* An asterisk sign (*) next to the value indicates that the value is likely invalid.